Eventide Asset Management - Q1 2019 holdings

$2.91 Billion is the total value of Eventide Asset Management's 131 reported holdings in Q1 2019. The portfolio turnover from Q4 2018 to Q1 2019 was 15.7% .

 Value Shares↓ Weighting
ASND  ASCENDIS PHARMA A Ssponsored adr$199,931,000
+87.9%
1,698,6480.0%6.88%
+46.0%
SAGE SellSAGE THERAPEUTICS INC$128,035,000
+42.8%
805,000
-14.0%
4.41%
+11.0%
TWLO BuyTWILIO INCcl a$106,832,000
+443.8%
827,000
+275.9%
3.68%
+322.5%
ZGNX BuyZOGENIX INC$104,244,000
+66.9%
1,895,000
+10.6%
3.59%
+29.7%
SRPT  SAREPTA THERAPEUTICS INC$100,736,000
+9.2%
845,1680.0%3.47%
-15.1%
TTD  THE TRADE DESK INC$95,214,000
+70.6%
481,0000.0%3.28%
+32.6%
W  WAYFAIR INCcl a$76,419,000
+64.8%
514,7770.0%2.63%
+28.1%
LOW  LOWES COS INC$61,851,000
+18.5%
565,0000.0%2.13%
-7.9%
ROP BuyROPER TECHNOLOGIES INC$60,529,000
+114.3%
177,000
+67.0%
2.08%
+66.5%
MYOV BuyMYOVANT SCIENCES LTD$58,936,000
+62.9%
2,469,021
+12.0%
2.03%
+26.6%
SPLK SellSPLUNK INC$53,329,000
-9.8%
428,000
-24.1%
1.84%
-29.9%
WCN BuyWASTE CONNECTIONS INC$53,331,000
+38.9%
602,000
+16.4%
1.84%
+8.0%
HUBS SellHUBSPOT INC$52,689,000
+19.7%
317,000
-9.4%
1.81%
-6.9%
PANW SellPALO ALTO NETWORKS INC$51,491,000
-9.2%
212,000
-29.6%
1.77%
-29.4%
MGTA BuyMAGENTA THERAPEUTICS INC$49,712,000
+235.6%
3,070,239
+15.8%
1.71%
+160.8%
BLUE BuyBLUEBIRD BIO INC$46,355,000
+68.3%
294,638
+6.1%
1.60%
+30.8%
AIMT BuyAIMMUNE THERAPEUTICS INC$43,851,000
+5.4%
1,962,000
+12.8%
1.51%
-18.1%
FIVN SellFIVE9 INC$42,845,000
+9.6%
811,000
-9.3%
1.47%
-14.8%
XPO  XPO LOGISTICS INC$42,347,000
-5.8%
788,0000.0%1.46%
-26.8%
LRCX  LAM RESEARCH CORP$40,635,000
+31.5%
227,0000.0%1.40%
+2.2%
CCI  CROWN CASTLE INTL CORP NEW$38,400,000
+17.8%
300,0000.0%1.32%
-8.5%
LII  LENNOX INTL INC$38,074,000
+20.8%
144,0000.0%1.31%
-6.1%
BPMC BuyBLUEPRINT MEDICINES CORP$36,983,000
+66.5%
462,000
+12.1%
1.27%
+29.5%
ANET BuyARISTA NETWORKS INC$36,792,000
+153.8%
117,000
+70.1%
1.27%
+97.2%
NEP SellNEXTERA ENERGY PARTNERS LP$36,776,000
+8.0%
788,500
-0.3%
1.26%
-16.1%
MTD BuyMETTLER TOLEDO INTERNATIONAL$34,704,000
+80.5%
48,000
+41.2%
1.19%
+40.3%
COLL  COLLEGIUM PHARMACEUTICAL INC$33,423,000
-11.8%
2,207,6100.0%1.15%
-31.5%
ASML  ASML HOLDING N V$32,533,000
+20.8%
173,0000.0%1.12%
-6.1%
QURE SellUNIQURE NV$32,133,000
+51.4%
538,700
-26.8%
1.11%
+17.8%
XYL NewXYLEM INC$31,379,000397,000
+100.0%
1.08%
KAR  KAR AUCTION SVCS INC$31,299,000
+7.5%
610,0000.0%1.08%
-16.4%
VMC BuyVULCAN MATLS CO$30,666,000
+182.2%
259,000
+135.5%
1.06%
+119.3%
MGA  MAGNA INTL INC$29,881,000
+7.1%
613,7000.0%1.03%
-16.8%
MNTA BuyMOMENTA PHARMACEUTICALS INC$29,542,000
+35.6%
2,033,144
+3.0%
1.02%
+5.4%
IMMU  IMMUNOMEDICS INC$27,125,000
+34.6%
1,412,0000.0%0.93%
+4.6%
PAYC  PAYCOM SOFTWARE INC$26,667,000
+54.5%
141,0000.0%0.92%
+20.2%
STLD  STEEL DYNAMICS INC$26,594,000
+17.4%
754,0000.0%0.92%
-8.8%
KALV  KALVISTA PHARMACEUTICALS INC$25,758,000
+44.9%
900,0000.0%0.89%
+12.6%
BHVN  BIOHAVEN PHARMACTL HLDG CO L$25,375,000
+39.2%
493,0000.0%0.87%
+8.2%
VRNS SellVARONIS SYS INC$25,045,000
-27.4%
420,000
-35.6%
0.86%
-43.5%
LEA  LEAR CORP$24,971,000
+10.5%
184,0000.0%0.86%
-14.2%
INST SellINSTRUCTURE INC$24,267,000
-19.7%
515,000
-36.1%
0.84%
-37.6%
IPHI  INPHI CORP$24,276,000
+36.1%
555,0000.0%0.84%
+5.7%
NBIX BuyNEUROCRINE BIOSCIENCES INC$23,787,000
+113.5%
270,000
+73.1%
0.82%
+66.1%
VCYT  VERACYTE INC$23,269,000
+98.9%
930,0000.0%0.80%
+54.6%
ALTR SellALTAIR ENGR INC$23,117,000
-16.2%
628,000
-37.2%
0.80%
-34.9%
ICPT BuyINTERCEPT PHARMACEUTICALS IN$22,931,000
+35.4%
205,000
+22.0%
0.79%
+5.2%
MYOK BuyMYOKARDIA INC$22,720,000
+54.0%
437,000
+44.7%
0.78%
+19.8%
PEGI SellPATTERN ENERGY GROUP INCcl a$22,660,000
+16.5%
1,030,000
-1.4%
0.78%
-9.4%
CTAS BuyCINTAS CORP$22,434,000
+167.1%
111,000
+122.0%
0.77%
+107.5%
FOLD BuyAMICUS THERAPEUTICS INC$21,964,000
+71.6%
1,615,000
+20.9%
0.76%
+33.3%
APTV BuyAPTIV PLC$21,860,000
+29.4%
275,000
+0.2%
0.75%
+0.5%
STML BuySTEMLINE THERAPEUTICS INC$20,682,000
+100.4%
1,609,523
+48.2%
0.71%
+55.8%
AVRO  AVROBIO INC$20,482,000
+37.5%
928,8910.0%0.70%
+6.8%
GLPG BuyGALAPAGOS NVspon adr$20,376,000
+455.2%
173,000
+332.5%
0.70%
+332.7%
TLND  TALEND S Aads$19,623,000
+36.4%
388,0330.0%0.68%
+6.0%
BOLD BuyAUDENTES THERAPEUTICS INC$19,471,000
+232.1%
499,000
+81.5%
0.67%
+157.7%
GBT  GLOBAL BLOOD THERAPEUTICS IN$19,425,000
+28.9%
367,0000.0%0.67%
+0.1%
PFPT  PROOFPOINT INC$19,186,000
+44.9%
158,0000.0%0.66%
+12.6%
ARGX SellARGENX SEsponsored adr$19,101,000
-21.7%
153,000
-39.8%
0.66%
-39.2%
HASI SellHANNON ARMSTRONG SUST INFR C$17,769,000
+33.6%
693,000
-0.7%
0.61%
+3.7%
WBC SellWABCO HLDGS INC$17,665,000
-35.6%
134,000
-47.6%
0.61%
-50.0%
VKTX  VIKING THERAPEUTICS INC$17,465,000
+29.9%
1,757,0000.0%0.60%
+1.0%
AY SellATLANTICA YIELD PLC$16,677,000
-1.7%
857,000
-1.0%
0.57%
-23.6%
GWPH BuyGW PHARMACEUTICALS PLCads$15,678,000
+153.5%
93,006
+46.5%
0.54%
+96.7%
STKL  SUNOPTA INC$14,880,000
-10.6%
4,300,5400.0%0.51%
-30.5%
STRO  SUTRO BIOPHARMA INC$13,770,000
+26.3%
1,244,8950.0%0.47%
-1.9%
MIC SellMACQUARIE INFRASTRUCTURE COR$13,417,000
-31.5%
325,500
-39.3%
0.46%
-46.8%
RCKT  ROCKET PHARMACEUTICALS INC$12,429,000
+18.4%
708,6000.0%0.43%
-8.0%
OKTA NewOKTA INCcl a$12,410,000150,000
+100.0%
0.43%
EXAS BuyEXACT SCIENCES CORP$12,127,000
+46.7%
140,000
+6.9%
0.42%
+13.9%
IFRX  INFLARX NV$10,392,000
+3.9%
275,0000.0%0.36%
-19.2%
ARQL BuyARQULE INC$10,059,000
+240.6%
2,100,000
+97.0%
0.35%
+164.1%
MDCO  MEDICINES CO$9,363,000
+46.0%
335,0000.0%0.32%
+13.4%
CRNX BuyCRINETICS PHARMACEUTICALS IN$8,740,000
+136.5%
384,000
+211.6%
0.30%
+83.5%
MGNX NewMACROGENICS INC$8,720,000485,000
+100.0%
0.30%
ARYAU  ARYA SCIENCES ACQUISITION COunit 10/04/2023$8,280,000
+1.1%
800,0000.0%0.28%
-21.5%
EXR  EXTRA SPACE STORAGE INC$8,153,000
+12.6%
80,0000.0%0.28%
-12.2%
THOR  SYNTHORX INC$8,148,000
+17.2%
400,0000.0%0.28%
-9.1%
RARX SellRA PHARMACEUTICALS INC$8,062,000
+14.2%
359,900
-7.2%
0.28%
-11.5%
SNSS BuySUNESIS PHARMACEUTICALS INC$7,248,000
+669.4%
5,965,455
+163.3%
0.25%
+492.9%
UROV  UROVANT SCIENCES LTD$6,723,000
+52.5%
669,0000.0%0.23%
+18.5%
WVE  WAVE LIFE SCIENCES LTD$6,620,000
-7.6%
170,4000.0%0.23%
-28.1%
RGEN  REPLIGEN CORP$6,499,000
+12.0%
110,0000.0%0.22%
-12.8%
XNCR  XENCOR INC$6,305,000
-14.1%
203,0000.0%0.22%
-33.2%
XENE BuyXENON PHARMACEUTICALS INC$6,306,000
+135.5%
620,691
+46.2%
0.22%
+82.4%
XLRN  ACCELERON PHARMA INC$6,003,000
+6.9%
128,9000.0%0.21%
-16.9%
ADVM  ADVERUM BIOTECHNOLOGIES INC$6,008,000
+66.3%
1,146,5800.0%0.21%
+29.4%
ETTX  ENTASIS THERAPEUTICS HLDGS I$5,776,000
+65.9%
879,5410.0%0.20%
+29.2%
KNSA  KINIKSA PHARMACEUTICALS LTD$5,761,000
-35.7%
319,0000.0%0.20%
-50.1%
ORTX  ORCHARD THERAPEUTICS PLCads$4,828,000
+13.7%
270,0000.0%0.17%
-11.7%
VRTX SellVERTEX PHARMACEUTICALS INC$4,783,000
-87.1%
26,000
-88.3%
0.16%
-89.9%
CBIO BuyCATALYST BIOSCIENCES INC$3,754,000
+93.4%
462,852
+88.2%
0.13%
+50.0%
CERC NewCERECOR INC$3,504,000600,000
+100.0%
0.12%
FENC  FENNEC PHARMACEUTICALS INC$3,492,000
-24.0%
720,0000.0%0.12%
-40.9%
VBIV  VBI VACCINES INC$3,460,000
+16.9%
1,850,0000.0%0.12%
-9.2%
BEP SellBROOKFIELD RENEWABLE PARTNERpartnership unit$2,508,000
-6.0%
78,500
-23.8%
0.09%
-27.1%
ABB BuyABB LTDsponsored adr$2,434,000
+0.8%
129,000
+1.6%
0.08%
-21.5%
FHB  FIRST HAWAIIAN INC$2,449,000
+15.7%
94,0000.0%0.08%
-10.6%
TERP SellTERRAFORM PWR INC$2,405,000
+19.1%
175,000
-2.8%
0.08%
-6.7%
HMC  HONDA MOTOR LTD$2,160,000
+2.7%
79,5000.0%0.07%
-20.4%
TSM SellTAIWAN SEMICONDUCTOR MFG LTDsponsored ads$2,028,000
-3.6%
49,500
-13.2%
0.07%
-24.7%
ETN  EATON CORP PLC$1,941,000
+17.3%
24,1000.0%0.07%
-8.2%
 HANNON ARMSTRONG SUST INFR Cnote 4.125% 9/0$1,921,000
+11.4%
1,894,0000.0%0.07%
-13.2%
MLHR SellMILLER HERMAN INC$1,794,000
+13.0%
51,000
-2.9%
0.06%
-11.4%
BDN SellBRANDYWINE RLTY TRsh ben int new$1,753,000
+18.9%
110,500
-3.5%
0.06%
-7.7%
EPIX BuyESSA PHARMA INC$1,653,000
+63.3%
481,971
+0.0%
0.06%
+26.7%
JCI SellJOHNSON CTLS INTL PLC$1,607,000
-7.4%
43,500
-25.6%
0.06%
-28.6%
CCIPRA  CROWN CASTLE INTL CORP NEW6.875% con pfd a$1,605,000
+12.6%
1,3550.0%0.06%
-12.7%
BG  BUNGE LIMITED$1,523,000
-0.7%
28,7000.0%0.05%
-23.5%
 DERMIRA INCnote 3.000% 5/1$1,065,000
+14.5%
1,200,0000.0%0.04%
-9.8%
ARE SellALEXANDRIA REAL ESTATE EQ IN$1,069,000
-7.2%
7,500
-25.0%
0.04%
-27.5%
APU  AMERIGAS PARTNERS L Punit l p int$1,019,000
+22.0%
33,0000.0%0.04%
-5.4%
PLD SellPROLOGIS INC$935,000
+6.1%
13,000
-13.3%
0.03%
-17.9%
ERIC SellERICSSONadr b sek 10$932,000
-4.5%
101,500
-7.7%
0.03%
-25.6%
GPMT  GRANITE PT MTG TR INC$910,000
+3.1%
49,0000.0%0.03%
-20.5%
NOK BuyNOKIA CORPsponsored adr$875,000
+499.3%
153,000
+512.0%
0.03%
+400.0%
LXP  LEXINGTON REALTY TRUST$725,000
+10.4%
80,0000.0%0.02%
-13.8%
CVA SellCOVANTA HLDG CORP$727,000
-32.3%
42,000
-47.5%
0.02%
-47.9%
IR NewINGERSOLL-RAND PLC$648,0006,000
+100.0%
0.02%
LPT SellLIBERTY PPTY TRsh ben int$508,000
-21.7%
10,500
-32.3%
0.02%
-41.4%
PSA  PUBLIC STORAGE$436,000
+7.7%
2,0000.0%0.02%
-16.7%
 MEDICINES COnote 2.750% 7/1$423,000
+11.6%
500,0000.0%0.02%
-11.8%
VTR SellVENTAS INC$383,000
-23.1%
6,000
-29.4%
0.01%
-40.9%
 ACORDA THERAPEUTICS INCnote 1.750% 6/1$355,000
+6.6%
400,0000.0%0.01%
-20.0%
CIG  COMPANHIA ENERGETICA DE MINAsp adr n-v pfd$232,000
+0.4%
65,0000.0%0.01%
-20.0%
NewHERCULES CAPITAL INCdbcv 4.375% 2/0$196,000200,000
+100.0%
0.01%
NXPI NewNXP SEMICONDUCTORS N V$177,0002,000
+100.0%
0.01%
WDC NewWESTERN DIGITAL CORP$144,0003,000
+100.0%
0.01%
NewPATTERN ENERGY GROUP INCnote 4.000% 7/1$101,000100,000
+100.0%
0.00%
CWEN SellCLEARWAY ENERGY INCcl c$91,000
-67.0%
6,000
-62.5%
0.00%
-75.0%
ExitHERCULES CAPITAL INCdbcv 4.375% 2/0$0-200,000
-100.0%
-0.01%
WELL ExitWELLTOWER INC$0-7,500
-100.0%
-0.02%
DERM ExitDERMIRA INC$0-334,000
-100.0%
-0.11%
GTTN ExitGTT COMMUNICATIONS INC$0-112,991
-100.0%
-0.12%
PTCT ExitPTC THERAPEUTICS INC$0-113,000
-100.0%
-0.17%
VYGR ExitVOYAGER THERAPEUTICS INC$0-436,000
-100.0%
-0.18%
DOOR ExitMASONITE INTL CORP NEW$0-170,000
-100.0%
-0.34%
BCRX ExitBIOCRYST PHARMACEUTICALS$0-1,047,000
-100.0%
-0.37%
WTRH ExitWAITR HLDGS INC$0-876,000
-100.0%
-0.43%
CRUS ExitCIRRUS LOGIC INC$0-370,000
-100.0%
-0.54%
LOXO ExitLOXO ONCOLOGY INC$0-274,000
-100.0%
-1.70%
SEND ExitSENDGRID INC$0-1,793,000
-100.0%
-3.43%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2019-05-15
Signatures

The EDGAR filing(s) were signed by:

About Eventide Asset Management

Eventide Asset Management is a Boston-based investment firm that specializes in providing investment solutions to investors who are looking for long-term growth opportunities. The company was founded in 2008 by a group of experienced investment professionals who shared a common vision of creating a firm that would focus on investing in companies that are making a positive impact on society.

The company's investment philosophy is based on the belief that companies that are making a positive impact on society are more likely to be successful in the long run. Eventide's investment team conducts extensive research to identify companies that are aligned with this philosophy and have the potential to deliver strong returns over the long term.

The company's investment strategies are managed by a team of experienced professionals, including CEO Robin John, COO Finny Kuruvilla, and Chief Investment Officer, Dr. Finny Kuruvilla. The team has a proven track record of delivering strong returns to investors, and their investment strategies have been recognized by industry experts.

Eventide Asset Management offers a range of investment solutions, including mutual funds, separately managed accounts, and exchange-traded funds (ETFs). The company's funds are available to individual investors, financial advisors, and institutional investors.

Overall, Eventide Asset Management is a reputable investment firm that has a strong focus on investing in companies that are making a positive impact on society. The company's experienced investment team and proven track record make it a compelling option for investors who are looking for long-term growth opportunities.

It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
LOWES COS INC40Q3 20233.2%
PALO ALTO NETWORKS INC40Q3 20233.6%
ASML HOLDINGS NV40Q3 20231.9%
NEUROCRINE BIOSCIENCES INC40Q3 20231.1%
REPLIGEN CORP40Q3 20230.5%
VERACYTE INC38Q3 20231.5%
LAM RESEARCH CORP35Q3 20233.4%
XPO LOGISTICS INC34Q1 20233.8%
COLLEGIUM PHARMACEUTICAL INC34Q3 20232.6%
MAGNA INTL INC33Q4 20212.5%

View Eventide Asset Management's complete holdings history.

Latest significant ownerships (13-D/G)
Eventide Asset Management Q1 2019 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
Cogent Biosciences, Inc.February 14, 20232,589,7783.7%
ESSA Pharma Inc.Sold outFebruary 14, 202300.0%
Freeline Therapeutics Holdings plcFebruary 14, 20235,920,7659.1%
KnowBe4, Inc.Sold outFebruary 14, 202300.0%
Praxis Precision Medicines, Inc.February 14, 20233,518,0627.5%
Prometheus Biosciences, Inc.February 14, 20231,032,9382.2%
SUTRO BIOPHARMA, INC.Sold outFebruary 14, 202300.0%
Vital Farms, Inc.Sold outFebruary 14, 202300.0%
Zymeworks Inc.Sold outFebruary 14, 202300.0%
Entasis Therapeutics Holdings Inc.February 14, 2022590,6021.2%

View Eventide Asset Management's complete significant-ownership history.

Latest filings
TypeFiled
13F-HR/A2024-02-20
13F-HR2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14

View Eventide Asset Management's complete filings history.

Compare quarters

Export Eventide Asset Management's holdings